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Cerebrovascular diseases are the second cause of mortality in the world, and hypertension is considered a main risk factor for
occurrenceofstroke.Themechanismsresponsiblefortheincreasedstrokeriskremainunclear.However,dietaryinterventionshave
beenappliedinthemanagementandtreatmentoftheirriskfactors,whichincludeincreasedbloodpressurelevels,obesity,diabetes,
and dyslipidemia. Further studies should be conducted to assess the eﬀects of carotenoids, ﬂavonoids, n-3 polyunsaturated fats,
and lower salt and high glycemic index intake in risk of stroke.
1.Introduction
The main risk factor for stroke is high blood pressure (BP)
and, when properly controlled, signiﬁcantly reduces the
incidence rates of this disease. Despite all advances achieved
in recent years, its prevention is a priority, and in this
respect, BP control has a prominent role [1]. An increase
has been observed in the number of cerebrovascular events
in developing countries that matches with food and lifestyle
changes arising from industrialization and urbanization
[2, 3]. Accurately assessing and understanding the role of
nutrition in the causes and consequences of stroke will
be crucial in developing and implementing strategies to
minimize the global burden of stroke [4]. The aim of this
paper is to describe the evidence linking nutrition to the risk
of stroke.
2. Role of Nutrients for Stroke Prevention
2.1.Salt. Saltisanessentialsubstancetomanandtoalltypes
of animal life. We can see the important role of salt through
the records of human history. However, during the past cen-
tury, the evidence for the risks imposed on human health by
excess salt consumption has become compelling. The causal
relationship between habitual dietary salt intake and BP has
beenestablishedthroughexperimental,epidemiological,and
even intervention studies. Most adult populations around
the world have average daily salt intake higher than 6g per
day although international recommendations suggest that
average population salt intake should be less than 5-6g per
day [4–6].
The relationship between salt intake and health is recog-
nized by the scientiﬁc community. Initially, this relationship
was made with the association between magnitude of salt
intake and hypertension. Two achievements make a major
impact on this subject, the quantitative measurement of
dietary sodium intake and repeated recognition that the
greater the daily sodium intake, the higher the prevalence
of hypertension in populations [7]. A series of population-
based intervention studies and randomized controlled clini-
cal trials have shown that it is possible to achieve signiﬁcant
reductions in BP with reduced salt intake in people with and
without hypertension [8–12].
The Intersalt multicenter study that included normoten-
sive and hypertensive patients was conducted in 52 centers
from diﬀerent countries in the 80s. This study showed that
dietaryintakeofsodium(100mmol/day)wasassociatedwith
diﬀerences in systolic pressure of approximately 2.2mmHg
after adjustment for age, gender, excretion of potassium,
body mass index, and alcohol intake [10].2 International Journal of Hypertension
Meta-analysis of intervention studies with salt restriction
showed reductions in systolic BP (3.7 to 7.0mmHg) and
in diastolic BP (0.9 to 2.5mmHg) in hypertensive patients
[8, 13]. The response of BP to sodium reduction is direct
and progressive, but nonlinear; decreasing sodium intake by
about 0.9g per day causes a greater reduction in BP when
the starting sodium intake is about 2.3g per day than when it
is about 3.5g per day [14, 15]. However, some researchers
believe that the participation of salt in hypertension is far
more complex than those reported by previous studies and
concluded that the postulate of salt overload leads to long-
term negative structural and functional changes of target
organs, regardless of its eﬀect on BP [7].
Increased levels of systolic and diastolic BP are asso-
ciated with the risk for developing coronary heart and
cerebrovascular disease. Hypertension is a major risk factor
for stroke and is associated with vascular disease in small
and large arteries. The risk posed by hypertension is higher
for heart failure and stroke, but in the countries of the
north west, coronary heart disease is the most common and
lethal condition [1, 16]. Therefore, it is natural to think that
reducingsaltintake,essentialpartofhypertensiontreatment,
also contributes to the prevention of stroke.
A meta-analysis of six randomized trials showed that a
reduction in dietary salt intake by 2.0–2.3g (half a teaspoon)
per day was associated with a reduction in cardiovascular
events by 20% (relative risk 0.80, 95% CI 0.64–0.99) [17].
However, no randomized trials evaluating the eﬀect of salt
reduction on risk of stroke or its pathological and etiological
subtypes have been done.
Another recent meta-analysis has clearly shown that
higher salt intake is associated with a greater incidence of
stroke and cardiovascular events. This systematic review
identiﬁed 13 relevant and suitable studies published from
1996 to 2008. These studies provided evidence from 170,000
peoplecontributingformorethan10,000vascularevents[5].
Many studies have assessed the associations between
dietary exposures and cardiovascular or stroke risk. The
ﬁndings are diverse, mainly because most studies are
epidemiological and prone to substantial methodological
challenges of bias, confounding factors, and measurement
error.
2.2. Coﬀee. Coﬀee is one of the most frequently consumed
beverages worldwide [18]. It has been documented to have
acute deleterious physiologic eﬀects within hours after con-
sumption, including increased systolic and diastolic BP, [19]
vascular resistance, [20] and impairment of endothelium-
dependent vasodilation [21]. Several mechanisms have been
proposed, including sympathetic overactivation, increased
norepinephrine release, renal eﬀects, and activation on the
renin-angiotensin system [19].
On the other hand, compounds in coﬀee may have
beneﬁcial eﬀects on the cardiovascular system. In addition
to minerals and trace elements, like potassium, magne-
sium, and manganese, the coﬀee is a source of phenolic
compounds, including chlorogenic acid. It is possible that
the minerals and polyphenols eﬀects on the cardiovascular
system would be higher than the adverse eﬀects of caﬀeine
[19]. The phenolic compounds in coﬀee possess antioxidant
capacity and can inhibit the oxidative modiﬁcation of low-
density lipoprotein [22] and may also have eﬀects on serum
cholesterolandhomocysteineconcentrations,oxidation,and
inﬂammation [23].
Chronic coﬀee consumption has been inconsistently
associated with risk of stroke. Lopez-Garcia and colleagues
(2009) have found that long-term coﬀee consumption was
not associated with an increased risk of stroke in a prospec-
tive cohort of 83,076 women without history of stroke. In
contrast, their data suggest that coﬀee consumption may
modestly reduce risk of stroke [24]. Another study, including
patients with type 2 diabetes, has observed no association
between coﬀe ea n dr i s ko ft o t a ls t r o k e[ 25].
In a cohort study with male Finnish smokers aged 50
to 69 years without a history of stroke at baseline, Larsson
and colleagues [26] showed that coﬀee consumption was
inversely associated with the risk of cerebral infarction, but
not intracerebral or subarachnoid hemorrhage, during a
mean followup of 13.6 years.
A meta-analysis of 11 prospective studies of 479,689
participants, in which relative risk of stroke for three or
more categories of coﬀee consumption was reported, has
concluded that moderate coﬀee consumption may be weakly
inversely associated with risk of stroke [18]. By contrast,
in a multicenter case-crossover study with 390 subjects, the
subject’s acute coﬀee consumption in the hour before stroke
symptoms was compared with his or her usual frequency of
consumption in the prior year. The authors have found that
coﬀee consumption transiently increases the risk of ischemic
stroke onset, particularly among infrequent drinkers [27].
It is unclear whether the relationship between coﬀee
consumption and stroke is due to potentially unfavorable
eﬀects of caﬀeine or due the polyphenols eﬀects. The studies
are controversial and present residual confounding from
other stroke risk factors related to coﬀee consumption.
Future studies should attempt to assess this association.
2.3. Flavonoids. Flavonoids (ﬂavonols, ﬂavones, and isoﬂa-
vones) are other dietary antioxidants compounds commonly
foundinconcentratedamountsinmultiplefruits,vegetables,
and beverages, including apples, berries, grapes, onions, red
wine, tea, cocoa, and dark chocolate [28]. They are charac-
terized by their inherent potent antioxidant eﬀects, with a
range of biochemical properties, such as antioxidant, antiin-
ﬂammatory, and antithrombotic eﬀects [29], inhibiting lipid
peroxidation,preventingatherosclerosis,promotingvascular
relaxation, and with antihypertensive properties [30] that
may explain beneﬁcial eﬀects on cardiovascular disease.
Hollmanandcolleagues[29]haveconductedameta-analysis
of six prospective cohort studies to assess quantitatively
the strength of the association between ﬂavonol intake and
stroke incidence. A high intake of ﬂavonols when compared
with a low intake was inversely associated with nonfatal and
fatal stroke, suggesting that ﬂavonols may reduce stroke risk.
During seven years of followup, a cohort study examined
the association between ﬂavonoid intake and cardiovascular
disease. In this study, ﬂavonoid consumption was associated
with lower risk of death from CVD, and total ﬂavonoidInternational Journal of Hypertension 3
intake was more strongly associated with stroke mortality
in men. The authors indicated that even relatively small
amounts of ﬂavonoid-rich foods may be beneﬁcial [31]. On
the other hand, Hirvonen and colleagues have found an
inverse association between dietary intake of beta-carotene
and the risk for cerebral infarction, but no association was
detected between other dietary antioxidants and risk for
stroke [32].
B e s i d e sﬂ a v o n o i d s ,s o m es t u d i e sh a v ei n v e s t i g a t e dt h e
relationship between foods and beverages that contain
polyphenolic compounds, like dark chocolate and tea. The
highest levels of chocolate consumption were associated with
a reduction in cardiovascular disease and stroke [33, 34].
The same results can be observed when the studies assess
the relationship between tea consumption and risk of stroke
[35–37].
2.4. Carotenoids. Carotenoids, the pigments responsible for
the yellow to red color of some fruits and vegetables, have
been implicated as beneﬁcial substances; they are found in
the human diet and primarily derived from plants and found
in roots, leaves, shoots, seeds, fruit, and ﬂowers [38]. Various
biological eﬀects have been attributed to carotenoids. A
possible mechanism of action is through the antioxidant
activity, but other mechanisms of protection may exist
[38]. The currently dietetic recommendation to increase
consumptionof fruitsandvegetablesrichin antioxidants has
generated interest in the role of carotenoids [39], but the
mechanisms are not clearly known. Some researchers have
evaluated their eﬀects in preventing cardiovascular disease.
Prospective studies have shown the association between
plasma levels of carotenoids and markers of inﬂammation,
oxidativestress,endothelialdysfunction[40,41],andarterial
stiﬀness [42]. Their many conjugated double bonds give
themanantioxidantpotential.Lycopeneisthemostpowerful
antioxidant among plasma carotenoids [43]. Its eﬀects have
been related to decreased risk of cardiovascular disease
[44, 45], including atherosclerosis [46] and myocardial
infarction [47]. These nutrients can aﬀect the risk of
stroke. The oxidation hypothesis of atherosclerosis points
out that oxidation of low-density lipoprotein cholesterol
(lipid peroxidation) allows it to accumulate in artery walls
promoting atherosclerosis [4].
There are a few studies associating carotenoids with
stroke. Rissanen and colleagues, in the Kuopio Ischaemic
Heart Disease Risk Factor Study, examined 725 men during
six years, associating serum lycopene levels and risk of
coronary heart disease and stroke. Men in the lowest quarter
o fs e ru ml y c o pe n el ev e l sh ada3 . 3 - f o l dri s ko fac u t ec o r o n a ry
heart events and stroke. These ﬁndings suggest that lycopene
might have a role in the prevention of coronary events
and stroke [48]. Another study conducted a prospective,
nested case-control analysis among male physicians without
diagnosed cardiovascular disease followed up for 13 years.
Samples from 297 physicians with ischemic stroke were ana-
lyzed with paired controls and matched forage and smoking,
for5majorcarotenoids(α-andβ-carotene,α-cryptoxanthin,
lutein, and lycopene), retinol, and α-a n dγ-tocopherol, and
risk of ischemic stroke was inversely related to plasma levels
of carotenoids [49]. Despite these ﬁndings, further studies
are needed to evaluate the association between carotenoids
compounds and the risk of stroke.
2.5. Fats. Bioactive compounds of interest in clinical studies
due to its antiarrhythmic eﬀect [50], having beneﬁcial
eﬀects on multiple cardiac disorders, are represented by n-
3-polyunsaturated fatty acids. The major food sources of n-
3-polyunsaturated fatty acids are deep and cold water ﬁsh
such as salmon, trout, and cod. The oils of many species
of marine ﬁsh are rich in eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), the two forms that have long
chains and active n-3-polyunsaturated family [51].
Fat is one of the diet variables that exerts direct inﬂuence
on cardiovascular risk factors [52]. For the treatment of
hypercholesterolemia, the dietary recommendations for fat
intake must be within a limit of 25–35% of the total calories,
divided in ≤7% saturated fats, ≤10% polyunsaturated fats,
and ≤20% monounsaturated fats [53]. Many studies suggest
that the disproportion in the consumption of n-6 and n-
3 fatty acids in the diet can lead to the development of
chronic diseases. Before this, global recommendations of n-
3 fatty acids for primary prevention of coronary diseases
correspond to regular intake of 2 servings of ﬁsh per week,
equivalent to 1g of EPA and DHA combination [54].
Although the beneﬁts attributed to ﬁsh intake on the
cardiovascular mortality have been suggested by observa-
tional studies [55–57], the eﬀects of ﬁsh consumption on the
risk of stroke still remain controversial [58]. There are few
studies that have examined the association of diﬀerent types
of ﬁsh with the subtype of stroke. According to a population-
based prospective study in the Swedish Mammography
Cohort, with a mean followup of 10.4 years, women in
the highest quintile of ﬁsh intake compared to those who
never consumed lean ﬁsh had a 33% lower risk of total
stroke.Inmultivariaterelativeriskanalysisoftotalstrokeand
hemorrhagic stroke, women who consumpted >3 servings
of lean ﬁsh/week compared to those who consumpted <1
servings of lean ﬁsh/week showed relative risk of 0.84 (95%
CI: 0.71, 0.98; P for trend = 0.049) and 0.67 (95% CI: 0.42,
1.08; P for trend = 0.08), respectively [58, 59].
Large clinical trials, such as Diet and Reinfarction
Trial (DART) [60] and the Gruppo Italiano per lo Studio
della Sopravivenza nell Miocardico Infarction Prevenzione
(GISSI), showed clear beneﬁts of n-3-polyunsaturated fatty
acids in reducing total mortality and sudden death. On
the other hand, the results of controlled clinical trials are
inconsistent in relation to the consumption of n-3 and stroke
[61].
Observationalstudiesconductedwiththealpha-linolenic
acid suggest a reduction in 35 to 50% on the stroke risk
with increasing its intake [62]. Its main sources are vegetable
oils such as soybean, canola, and ﬂaxseed, and also in
walnuts [4]. The adoption of the Mediterranean diet, which
encompasses the increased alpha-linolenic acid intake, a
reduction in saturated fat, and a modest increase in ﬁber4 International Journal of Hypertension
and total carbohydrate, was associated with a 72% reduction
in recurrent coronary heart events in patients with prior
myocardial infarction [63, 64].
It is well known that the saturated fat inﬂuences the
plasma lipid levels, particularly in cholesterolemia [53].
Scientiﬁc evidence suggests that replacing saturated fat by
polyunsaturated or monounsaturated fat is able to reduce
both HDL- and LDL-cholesterol. However, the results of
dietary interventions involving such a replacement for the
reduction of cardiovascular events are not consistent [65].
2.6. Carbohydrates. Carbohydrates are the main source of
energy for the body and daily nutrient recommendations
are based on the Dietary Reference Intakes (DRIs) by age
and gender. The Dietary Guidelines for Americans suggest
that about half (45–65%) of your daily calories should
come from carbohydrates (starches, ﬁber, and sugars) [66].
However, estimates indicate that the total caloric intake
exceedsDRIsregardlessofenergyneeds,andtheevidencefor
the risks imposed on human health by excess carbohydrates
consumption might be an increase in the development of
insulin resistance, diabetes, stroke, and cardiovascular dis-
ease [67–69]. The relationship between intake of sugars and
cardiovascular health has emerged since the last American
Heart Association (AHA) scientiﬁc statement was published
in 2002 [70]. In 2006, the AHA published revised diet
and lifestyle recommendations that propose minimizing the
intake of beverages and foods with added sugars [71].
Strong evidence shows that the total number of calories
consumed is the essential dietary factor relevant to body
weight gain and adiposity [72], and the quality of carbohy-
drate intake also aﬀects metabolic health. The proportion of
macronutrients takes into account both chronic disease risk
reduction and intake of essential nutrients. However, due to
the considerable increase in prevalence of obesity and related
chronic diseases, the AHA recently released a scientiﬁc
statement recommending reductions in added-sugar intake
to no more than 100 to 150kcal/d for most Americans
[73, 74]. Cross-sectional studies in humans link soft drink
consumptionwithhigherenergyintake,greaterbodyweight,
and poor nutrition [75] and suggest that excessive fructose
consumption is playing a role in the epidemics of insulin
resistance, obesity, hypertension, stroke, dyslipidemia, and
type 2 diabetes mellitus in humans [76–80], whereas overall
carbohydrate intake is less strongly related to these diseases.
Currently, increased risk of stroke mortality is associated
not only with high intake of carbohydrate, but also with
the dietary glycemic index (GI) and glycemic load (GL).
A recent study suggests that the risk of mortality from
ischemicstrokeisincreasedwithincreasedlevelofthedietary
GI among women [67]. A positive trend is also suggested
between dietary GL and mortality from hemorrhagic stroke
among women [81, 82]. A meta-analysis study provides
high-level evidence that diets with a high GI, high GL, or
both, independently of known confounders, including ﬁber
intake, increase the risk of chronic lifestyle-related diseases.
Overall, GI had a more powerful eﬀect than did the GL, with
more positive associations between GI and chronic disease
risk [83, 84].
It is known that the increased ﬁber intake reduces blood
pressure,bloodglucose,serumtriglycerides,andLDLcholes-
terol [4, 85] and may decrease the risk of chronic diseases by
improving the postprandial glycemic response and insulin
concentration. The type of ﬁber could be diﬀerentially
related to risk of the diseases. Instead, recent study suggested
that the risk of stroke is decreased with increased whole
grain intake and was associated with micronutrients that
accompany ﬁber in whole-grain cereal, contributing to lower
risk of stroke [82]. Some studies suggest that whole grain
or cereal ﬁber intakes as a source of ﬁber, among diﬀerent
sources of ﬁber, were inversely associated with risk of stroke
in US men [82, 85].
3. Conclusion
In summary, evidence shows that association between the
magnitude of salt intake and hypertension may increase
risk in both myocardial infarction and stroke. Moreover, the
excessiveintake ofnutrient-dense formsof foods has become
compelling, and the population has diﬃculty in following
low-calorie diet to promote weight loss over time. Sugar-
sweetenedbeveragesarecontributorstoaddsugarintakeand
weight gain and can lead to increased risk of stroke. A diet
rich in whole grains, fruits, and vegetables may help reduce
body weight and provide adequate amounts of ﬂavonoids,
carotenoids, minerals, and trace elements, which can help to
reduce chronic disease risk and stroke.
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